CYP17 gene polymorphism and its association in north Indian prostate cancer patients

Anticancer Research

Volumn 29, Issue 5, 2009, Pages 1659-1663

  Sobti, Ranbir Chander ^a   Gupta, Lipsy ^a   Thakur, Hitender ^a   Seth, Amlesh ^b   Singh, Sharwan K ^c   Kaur, Pushpinder ^a  

^a PANJAB UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

BPH; CYP17 gene polymorphism; Hormonal genes; North India; Prostate cancer

Indexed keywords

CYTOCHROME P450 17; TESTOSTERONE;

ARTICLE; BACTERIAL GENE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DIET; DNA POLYMORPHISM; GENE AMPLIFICATION; GENOTYPE; HUMAN; INDIA; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING;

AGED; BASE SEQUENCE; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 67650093561     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543, 2001.
2. Jemal A, Murray T, Ward E et al: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
3. Pu YS, Chiang HS, Lin CC et al: Changing trends of prostate cancer in Asia. The Aging Male 7: 120-132, 2004. (Pubitemid 39272935)
4. Pal SK and Mittal B: Improving cancer care in India: prospects and challenges. Asian Pacific J Cancer Prev 5: 226-228, 2004.
5. Hsing AW and Chokkalingam AP: Prostate cancer epidemiology. Front Biosci 1: 1388-1413, 2006.
6. Gann PH, Hennekens CH, Ma J et al: Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88: 1118-1126, 1996. (Pubitemid 26274606)
7. Picado-Leonard J and Miller WL: Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA 6: 439-448, 1987. (Pubitemid 18085844)
8. Feigelson HS, Coetzee GA, Kolonel LN et al: A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57: 1063-1065, 1997.
9. Sobti RC, Kaur P, Kaur S et al: Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer. Biomarkers 13: 282-295, 2008.
10. Sobti RC, Kordi Tamandani DM, Shekari M et al: Interleukin 1 beta gene polymorphism and risk of cervical cancer. Int J Gynaecol Obstet 101: 47-52, 2008.
11. Sobti RC, Singh J, Kaur P et al: XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population. Cancer Genet Cytogenet 175: 91-97, 2007.
12. Sobti RC, Kaur P, Kaur S et al: Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population. Cancer Genet Cytogenet 170: 108-114, 2006.
13. Sobti RC, Kaur P, Kaur S et al: No association of DNA ligase-I polymorphism with the risk of lung cancer in north Indian population. DNA Cell Biol 25: 484-489, 2006.
14. Sobti RC, Onsory K, Al-Badran AI et al: CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in a North Indian population. DNA Cell Biol 25: 287-294, 2006.
15. Sobti RC, Kaur S, Kaur P et al: Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genet Cytogenet 166: 117-123, 2006.
16. Sobti RC, Al-Badran AI, Sharma S et al: Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156: 68-73, 2005.
17. Sobti RC, Sharma S, Joshi A et al: Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 266: 1-9, 2004.
18. Sobti RC, Sharma S, Joshi A et al: CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. Biomarkers 8: 415-428, 2003.
19. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. 1-18.8, 1989.
20. Allen NE, Forrest MS, Key TJ: The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5α2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomark Prev 10: 185-189, 2001.
21. Sanda MA, Beaty TH, Stutzman RE et al: Genetic susceptibility of benign prostatic hyperplasia. J Urol 152: 115-119, 1994. (Pubitemid 24175715)
22. Partin AW, Oesterling JE, Epstein JI et al: Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 145: 405-409, 1991.
23. Greenwald P, Kirmiss V, Polan AK et al: Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53: 335-340, 1974.
24. Yamada Y, Watanabe M, Murata M et al: Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population. Int J Cancer 92: 683-686, 2001.
25. Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C and Micksche M: A. polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 87: 434-437, 2000.
26. Kittles RA, Panguluri RK, Chen W et al: CYP17 promoter variant associated with prostate cancer aggressiveness in African-Americans. Cancer Epidemiol Biomark Prev 10: 943-947, 2001.
27. Wadelius M, Andersson AO, Johansson JE et al: Prostate cancer associated with CYP17 genotype. Pharmacogenetics 9: 635-639, 1999.
28. Habuchi T, Liqing Z, Suzuki T et al: Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Cancer Res 60: 5710-5713, 2000.
29. Ntais C, Polycarpou A and Tsatsoulis A: Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes. Eur J Endocrinol 149: 469-477, 2003. (Pubitemid 38054690)
30. Dai WS, Gutai JP, Kuller LH et al: Cigarette smoking and serum sex hormones in men. Am J Epidemiol 128: 796-805, 1988. (Pubitemid 18245019)
31. Field AE, Colditz GA, Willett WC et al: The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 79: 1310-1316, 1994. (Pubitemid 24369840)